Urogen Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for UROGEN PHARMA, and what generic alternatives to UROGEN PHARMA drugs are available?
UROGEN PHARMA has one approved drug.
There are two US patents protecting UROGEN PHARMA drugs.
There are eight patent family members on UROGEN PHARMA drugs in six countries.
Drugs and US Patents for Urogen Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Urogen Pharma | JELMYTO | mitomycin | POWDER;PYELOCALYCEAL | 211728-001 | Apr 15, 2020 | RX | Yes | Yes | 9,040,074 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Urogen Pharma | JELMYTO | mitomycin | POWDER;PYELOCALYCEAL | 211728-001 | Apr 15, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Urogen Pharma | JELMYTO | mitomycin | POWDER;PYELOCALYCEAL | 211728-001 | Apr 15, 2020 | RX | Yes | Yes | 9,950,069 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Urogen Pharma Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 2734187 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2011089604 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2013011504 | ⤷ Try a Trial |
Spain | 2732150 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.